Join Mabqi’s team at the 14th Antibody Industrial Symposium in Montpellier !

We are delighted to announce that a large part of the Mabqi team will be attending the 14^th Antibody Industrial Symposium 2026 jointly organized by the scientific society LabEx MAbImprove and MabDesign, the French association of the Biotherapy Industrial sector, on June 30-July 1 2026, in Montpellier, France.

The AIS2026 is the ideal conference for scientists, industrials, clinicians, and policy makers to exchange about therapeutic antibodies and more! This year’s 2-days-programme is organized into several tracks covering the hot topics in antibody, recombinant proteins, and other biopharmaceuticals research and development.

We are honored to be giving two oral presentations on Day 1- Tuesday, June 30:

• “Next-Generation Tumor-Specific Anti-CD30 ADC as a New Therapy in Hemato-Oncology” at 3pm
• “MQI-201: A Pan-Cancer Immunotherapy Targeting TRPV6 to Convert Cold Tumors Into Hot Tumors” at 4:30pm